Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Respiratory Medicine

Topics

Medicine

Pathology

Physiology

Internal Medicine

Surgery

Show all topics

DOI

10.1016/s2213-2600(20)30554-3

Other Formats

PDF